comparemela.com

Latest Breaking News On - European medicines agency emergency task - Page 1 : comparemela.com

Moderna Submits Updated COVID-19 Jab to FDA for Review - ALX Oncology Holdings (NASDAQ:ALXO), Moderna (NASDAQ:MRNA)

Moderna, Inc. (NASDAQ: MRNA) announced that it has submitted an application to the FDA seeking approval of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1, the latest variant of the novel virus responsible for the 2020 pandemic.

We May Need a New Defense Against New COVID Variants

ATAGI Recommends Bivalent Covid Vaccines for 12+ Primary Vaccination

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.